Back

Prolonged dual antiplatelet therapy did not affect survival after left main artery stenting (Hong Kong Left Main Stenting Registry)

28 August 2017 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 5 - PCI - Adjunctive drug therapy PCI - Adjunctive drug therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Chi Yeung Cheung

Pedder Health, Hong Kong (Hong Kong)

13 More presentations in this session

Presentation thumbnail
Associate Professor B. Zheng (Beijing, CN)
Abstract Slides
Presentation thumbnail
Doctor S. Cornara (Savona, IT)
Abstract Slides
Presentation thumbnail
Professor Y. Lopatin (Volgograd, RU)
Abstract
Presentation thumbnail
Doctor C. Chen (Taipei, TW)
Abstract Slides
Presentation thumbnail
Assistant Professor M. Popescu (Bucharest, RO)
Abstract

Access the full session

Session thumbnail
Poster session 5 - PCI - Adjunctive drug therapy

The Event

Event poster

ESC Congress 2017

28 August 2017 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Percutaneous coronary intervention with 2nd generation drug eluting stent versus coronary artery bypass grafting in patients with unprotected left main disease: clinical outcome from a referral center
1 September 2019
thumbnail
Congress Session
Dual antiplatelet therapy titration after percutaneous coronary intervention: when to escalate, de-escalate, withdraw, and more
28 August 2023
thumbnail
Congress Presentation
Reduction of major adverse and major cardiovascular events in patients with atrial fibrillation and stent implantation treated with left atrial occlusion device vs oral anticoagulants strategy.
26 August 2022
thumbnail
Congress Presentation
Antiplatelet therapy and prognosis at the onset of stent thrombosis
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources